![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 413/14 | (2006.01) |
C07D 491/08 | (2006.01) | ||
C07D 403/04 | (2006.01) | ||
C07D 413/04 | (2006.01) | ||
C07D 417/04 | (2006.01) | ||
C07D 487/08 | (2006.01) | ||
A61K 31/4184 | (2006.01) | ||
A61P 35/00 | (2006.01) | ||
A61P 29/00 | (2006.01) |
(11) | Number of the document | 3350177 |
(13) | Kind of document | T |
(96) | European patent application number | 16778936.1 |
Date of filing the European patent application | 2016-09-16 | |
(97) | Date of publication of the European application | 2018-07-25 |
(45) | Date of publication and mention of the grant of the patent | 2021-07-07 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2016/052104 |
Date | 2016-09-16 |
(87) | Number | WO 2017/049068 |
Date | 2017-03-23 |
(30) | Number | Date | Country code |
201562220307 P | 2015-09-18 | US |
(72) |
JORAND-LEBRUN, Catherine , US
LAN, Ruoxi , US
CHEN, Austin , US
CLARK, Ryan C. , US
|
(73) |
Merck Patent GmbH ,
Frankfurter Strasse 250, 64293 Darmstadt,
DE
|
(54) | HETEROARYL COMPOUNDS AS IRAK INHIBITORS AND USES THEREOF |
HETEROARYL COMPOUNDS AS IRAK INHIBITORS AND USES THEREOF |